VERSICAN PLUS BB ORAL LYOPHILISAT AND SOLVENT FOR ORAL SUSPENSION FOR DOGS
VERSICAN PLUS BB ORAL LYOPHILISAT AND SOLVENT FOR ORAL SUSPENSION FOR DOGS
Authorised
- WATER, PURIFIED
- Bordetella bronchiseptica, strain 92 B, Live
Product identification
Medicine name:
VERSICAN PLUS BB ORAL LYOPHILISAT AND SOLVENT FOR ORAL SUSPENSION FOR DOGS
Versican Plus Bb Oral kuiva-aine, kylmäkuivattu, ja liuotin, oraalisuspensiota varten
Active substance:
- WATER, PURIFIED
- Bordetella bronchiseptica, strain 92 B, Live
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
WATER, PURIFIED1.00millilitre(s)1.00Dose
-
Bordetella bronchiseptica, strain 92 B, Live140000000.00Colony forming unit1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Available in:
-
Finland
Package description:
- Plastic box containing 5, vials of 1 dose of lyophilisate and 5, vials of 1ml of solvent
- Plastic box containing 25 vials of 1 dose of lyophilisate and 25 vials of 1ml of solvent
- Plastic box containing 10 vials of 1 dose of lyophilisate and 10 vials of 1ml of solvent
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium SA
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 36842
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0401/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 11/01/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 11/01/2024
How useful was this page?: